Trial Details

COMPLETED
Basic Information
Clinical ID c1079
Identifier NCT00573794
Trial Title Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis
Interventions BIOLOGICAL: adalimumab
Participant Information
Sponsor AbbVie (prior sponsor, Abbott)
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2007-11-28
Primary Completion Date 2025-12-16
Completion Date 2025-12-16